Oslo Sports Trauma Research Center, Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.
Orthopedic Department, Sørlandet Hospital Kristiansand, Kristiansand, Norway.
Am J Sports Med. 2024 Nov;52(13):3314-3323. doi: 10.1177/03635465241284648. Epub 2024 Oct 22.
The long-term prognosis of jumper's knee and whether structural changes in the patellar tendon persist is unknown.
To investigate whether limitations in knee function and structural changes persisted beyond the athletic career of young elite volleyball players.
Cohort study; Level of evidence, 2.
Volleyball players (mean ± SD age, 18 ± 0.8 years) enrolled in 2006-2011 in a prospective cohort study were invited in 2020-2022 to a follow-up study. Participants rated their knee function with the Victorian Institute of Sport Assessment-Patellar Tendon (VISA-P) score (baseline and follow-up) and the International Knee Documentation Committee (IKDC) score (follow-up) and reported if jumper's knee had influenced their decision to retire from sport. Tendon thickness and structural changes were assessed with ultrasound (baseline) and magnetic resonance imaging (MRI) (follow-up) of both patellar tendons.
We included 138 of 143 former athletes (97%) 11.4 ± 1.6 years after their baseline examination. At baseline, 37 persons (52 knees) had developed jumper's knee. At follow-up, participants reported lower knee function scores in knees diagnosed with jumper's knee at baseline than healthy knees (VISA-P scores: jumper's knee, 81 [95% CI, 70-92]; healthy, 90 [95% CI, 86-94]; < .001; IKDC scores: jumper's knee, 82 [95% CI, 75-89]; healthy, 92 [95% CI, 91-95]; < .001). Jumper's knee problems directly caused 7 of the 37 athletes (19%) with jumper's knee at baseline to retire from competitive volleyball. Of the 138 players included, 97 (70%) completed a bilateral MRI examination (194 knees). At follow-up, 38 of the 54 abnormal tendons (70%) had no structural changes ( < .001 vs baseline) while 22 of the 140 normal tendons (16%) had developed structural changes. Clinical symptoms were not correlated with tendon structure at follow-up (VISA-P scores for normal tendons: 85 [95% CI, 73-87]; abnormal: 89 [95% CI, 85-92]; = .48).
Jumper's knee is not a self-limiting condition; volleyball players who had developed jumper's knee during adolescence reported persistent reductions in knee function 11 years later, leading one-fifth to retire from competitive volleyball. Although approximately 70% of tendons with structural changes at baseline were normal at follow-up, there was no clear relationship between structure and function.
目前尚不清楚跳跃膝的长期预后以及髌腱的结构变化是否持续存在。
研究年轻精英排球运动员结束运动生涯后,膝关节功能是否仍受限,结构变化是否持续存在。
队列研究;证据等级 2。
2006 年至 2011 年期间,入选一项前瞻性队列研究的排球运动员(平均年龄±标准差,18±0.8 岁)受邀于 2020 年至 2022 年参加随访研究。参与者使用维多利亚运动评估-髌腱(VISA-P)评分(基线和随访)和国际膝关节文献委员会(IKDC)评分(随访)评估膝关节功能,并报告跳跃膝是否影响其决定退役。使用超声(基线)和 MRI(随访)评估双侧髌腱的厚度和结构变化。
我们纳入了 138 名(97%)曾参加基线检查的前运动员,在随访时距基线检查 11.4±1.6 年。基线时,37 名运动员(52 个膝关节)出现跳跃膝。在随访时,与健康膝关节相比,基线时诊断为跳跃膝的膝关节参与者报告的膝关节功能评分更低(VISA-P 评分:跳跃膝为 81[95%CI,70-92];健康膝关节为 90[95%CI,86-94];<0.001;IKDC 评分:跳跃膝为 82[95%CI,75-89];健康膝关节为 92[95%CI,91-95];<0.001)。基线时患有跳跃膝的 37 名运动员中有 7 名(19%)因该疾病直接退役。在 138 名运动员中,97 名(70%)完成了双侧 MRI 检查(194 个膝关节)。在随访时,54 个异常肌腱中有 38 个(70%)无结构变化(<0.001 与基线相比),而 140 个正常肌腱中有 22 个(16%)出现了结构变化。临床症状与随访时的肌腱结构无相关性(正常肌腱的 VISA-P 评分:85[95%CI,73-87];异常肌腱为 89[95%CI,85-92];=0.48)。
跳跃膝不是一种自限性疾病;青春期出现跳跃膝的排球运动员 11 年后仍报告膝关节功能持续下降,导致五分之一的人退役。尽管大约 70%的基线时有结构变化的肌腱在随访时正常,但结构与功能之间无明确关系。